Clover Health Investments, Corp.
CLOV
$3.10
-$0.07-2.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 38.17% | 2.51% | |||
| Total Other Revenue | -13.66% | -25.26% | |||
| Total Revenue | 37.21% | 1.81% | |||
| Cost of Revenue | 45.42% | -2.69% | |||
| Gross Profit | 15.94% | 15.65% | |||
| SG&A Expenses | -4.63% | 27.53% | |||
| Depreciation & Amortization | 35.47% | 1.47% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 29.35% | 5.32% | |||
| Operating Income | 94.06% | -130.05% | |||
| Income Before Tax | 94.07% | -144.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 94.07% | -144.52% | |||
| Earnings from Discontinued Operations | -- | -65.14% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 94.23% | -141.31% | |||
| EBIT | 94.06% | -130.05% | |||
| EBITDA | 96.17% | -134.91% | |||
| EPS Basic | 94.21% | -140.11% | |||
| Normalized Basic EPS | 94.14% | -129.41% | |||
| EPS Diluted | 94.30% | -119.23% | |||
| Normalized Diluted EPS | 94.14% | -129.41% | |||
| Average Basic Shares Outstanding | 1.05% | 0.34% | |||
| Average Diluted Shares Outstanding | 1.05% | 0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||